DVT and Pulmonary Embolus: New Insights and Interventions
Deep venous thrombosis (DVT) and pulmonary embolism (PE) are the two most important manifestations of venous thromboembolism (VTE), which is the third most common life-threatening cardiovascular disease – after myocardial infarction and stroke – in the United States. According to the Centers for Disease Control and Prevention, the annual incidence of VTE is one or two per 1,000 persons, and the overall mortality rate is between 60,000 and 100,000 annually. Dr. John A. Kaufman will provide an update on recent advances in the diagnosis and therapy of DVT and PE.
Cardiologists, Vascular Surgeons, Interventional Radiologists, Interventional Cardiologists, Primary Care Physicians, Emergency Medicine Physicians, General Internists, Nurses, Advanced Practice Registered Nurses, Podiatrists and other interested healthcare providers.
- Describe current indications, techniques and outcomes for intervention in DVT and acute PE.
- Implement evidence-based risk stratification of patients presenting with DVT or acute PE, and initiate appropriate treatment.
John A. Kaufman, M.D., M.S., FSIR, FAHA, FCIRSE, EBIR
Chair, Department of Interventional Radiology
Director, Dotter Interventional Institute
Frederick S. Keller Professor of Interventional Radiology
Oregon Health & Science University
John A. Kaufman, M.D., faculty for this educational event, is a consultant for Argon, Cook Medical, Medyx.ai, and Shape Memory Medical. In addition, he is a stockholder in Auxetics, Hatch Medical, Endoshape and VuMedi. Dr. Kaufman has indicated that the presentation or discussion will include off-label or unapproved product usage.
Barry T. Katzen, M.D., conference director for this educational activity, has disclosed that consultant for Phillips, Gore and Boston Scientific.
Howard Katzman, M.D., conference director for this educational activity, has no relevant financial relationship to disclose with ineligible companies.*
All of the relevant financial relationships listed for these individuals have been mitigated.
Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships to disclose with ineligible companies.*
*Ineligible companies – Companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
Baptist Health South Florida designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.25 AMA PRA Category 1 Credit™
- 1.25 General certificate of attendance
- 1.00 Nurse Practitioners
- 1.00 Florida Board of Nursing
- 1.25 Florida Board of Podiatric Medicine
This site is supported on the most recent stable releases of the following browsers:
This site is supported on the following mobile devices:
If you are experiencing technical difficulties or have received an error message, please send an email to CME@baptisthealth.net and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours.